Konan partners with Chart2020

Article

Konan Medical USA, Inc. recently announced it has entered into an exclusive agreement with Chart2020, a provider of visual acuity and ocular performance testing software. Konan will develop, market, and distribute Chart2020 globally.

Irvine, CA-Konan Medical USA, Inc. recently announced it has entered into an exclusive agreement with Chart2020, a provider of visual acuity and ocular performance testing software. Konan will develop, market, and distribute Chart2020 globally.

Chart2020 v5 is an vision testing software platform with a redesigned user experience that can be controlled with the Chart2020 Duo app for iPad. The iPad can also be used to administer a number of guided, self-scoring tests including ColorDx, Konan’s new color vision testing software.

Central to Chart2020’s innovative user experience are SmartDocks, which enable users to quickly and easily access test libraries, sequences, system settings and Konan Wizards, a suite of guided, self-scoring tests. Examples of Wizards include stereo acuity, contrast sensitivity and ColorDx color vision diagnostics. Additionally, Chart2020 features global Sloan compliant optotypes for non-Western languages including Japanese, Korean, Russian, and Arabic, as well as Konan Kids, an optotype designed for children and illiterate adults.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Dr Luke Lindsell discusses retinal therapy and geographic atrophy at Controversies in Modern Eye Care 2025
Neda Shamie, MD, speaks on cataract and refractive surgery at CIME 2025.
Dr Selina McGee shares thoughts on pharmacological presbyopia correction at Controversies in Modern Eye Care 2025
Paul Hammond, OD, FAAO, presents a poster at ARVO 2025 on the creation of a conversion factor between 2 OCT devices to monitor glaucoma progression
What to know about legislative moves that have been made through May this year.
CIME 25: Dilsher Dhoot, MD, FASRS, is excited about emerging retinal therapies.
Robert Maloney, MD, MA, at the 2025 Controversies in Modern Eye Care meeting
Dr Jacob Lang at the 2025 Controversies in Modern Eye Care meeting
Steven Ferrucci, OD, FAAO, at Controversies in Modern Eyecare 2025
© 2025 MJH Life Sciences

All rights reserved.